Study finds melanoma biomarkers predicting checkpoint blocker response
Study finds melanoma biomarkers predicting checkpoint blocker response Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood of severe side effects. While the utility of these biomarkers needs to be validated in future clinical trials,…